From: Markers associated with genomic instability, immunogenicity and immune therapy responsiveness in Metaplastic carcinoma of the breast: Expression of γH2AX, pRPA2, P53, PD-L1 and tumor infiltrating lymphocytes in 76 cases
gH2AX
RPA2
tcPD-L1
icPD-L1
sTIL
0.530
(p < 0.0005)
-0.045*
-0.085*
-0.157
(p = 0.034)
-0.124*
0.453
(p = 0.001)
0.051*
-0.059*
0.199*
iTIL
0.094*
0.076*
0.295
(p = 0.007)
0.007*
0.041*